Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 1

Alternative Names

  • SLC2A1
  • Glucose Transporter 1
  • GLUT
  • GLUT1
  • Erythrocyte/Hepatoma Glucose Transporter
Back to search Result
OMIM Number

138140

NCBI Gene ID

6513

Uniprot ID

P11166

Length

33,516 bases

No. of Exons

10

No. of isoforms

1

Protein Name

Solute carrier family 2, facilitated glucose transporter member 1

Molecular Mass

54084 Da

Amino Acid Count

492

Genomic Location

chr1:42,925,353-42,958,868

Gene Map Locus
1p34.2

Description

The high metabolic requirements of the mammalian central nervous system require specialized structures for the facilitated transport of nutrients across the blood-brain barrier. The SLC2A1 gene encodes a major glucose transporter in the mammalian blood-brain barrier that is the facilitative glucose transporter GLUT1. This protein is expressed on endothelial cells at the blood-brain barrier and is responsible for facilitating transport of glucose across the luminal and abluminal endothelial membranes of the cerebral microvessel. Glut1 also facilitates transport of glucose across the astroglial plasma membrane, thus, representing the fundamental vehicle by which glucose enters the brain. Additionally, the transporter recognizes other substrates such as galactose, glycopeptides, water, and dihydroascorbic acid (DHA), some or all of which may also be translocated in significant amounts.

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_006516.4:c.115-4561=United Arab EmiratesNC_000001.11:g.42935767=AssociationType 2 Diabetes MellitusNG_008232.1:g.28410= ; NM_006516.4:c.115-4561=841853
NM_006516.4:c.1279-2A>CLebanonchr1:42927243Likely PathogenicGLUT1 Deficiency Syndrome 1NG_008232.1:g.36934A>C; NM_006516.4:c.1279-2A>C

Other Reports

Qatar

In a 6-year-old girl, born of consanguineous Arab parents from a Bedouin kindred from Qatar, with GLUT1 deficiency syndrome-1, Klepper et al. (2009) identified a homozygous c.1402C>T transition in exon 10 of the SLC2A1 gene, resulting in an arg468-to-trp (R468W) substitution. She was noted to have unsteady ataxic gait at age 18 months, as well as paroxysmal choreoathetosis. She also had developmental delay and hypotonia. EEG showed a polymorphic baseline alpha-theta activity with an isolated monomorphic sharp wave focus. Lumbar puncture showed hypoglycorrhachia and decreased CSF lactate. Her clinically asymptomatic 2-year-old sister was also homozygous for the mutation; she was found to have hypoglycorrhachia and decreased CSF lactate. The parents, who were unaffected, were heterozygous for the mutation. Klepper et al. (2009) concluded that the mutation was pathogenic, since the affected residue is highly conserved, is located in the C terminus which is essential for substrate recognition and transport, and was not found in 120 control alleles. Klepper et al. (2009) suggested that the unaffected sister who was homozygous for the mutation was too young for symptom onset. The findings suggested that GLUT1 deficiency can also be inherited in an autosomal recessive pattern.

© CAGS 2024. All rights reserved.